EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Syntaxin-6 delays prion protein fibril formation and prolongs the presence of toxic aggregation intermediates

Daljit Sangar, Elizabeth Hill, Kezia Jack, Mark Batchelor iD, Beenaben Mistry, Juan M Ribes, Graham S Jackson, Simon Mead, Jan Bieschke iD

eLife · 2024

DOI: 10.7554/elife.83320 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Daljit Sangar und 8 weiteren Autor:innen. Beteiligte Einrichtung: MRC Prion Unit at UCL, Institute of Prion Diseases, London, United Kingdom. Hauptthemen laut MEDLINE: Qa-SNARE Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Medical Research Council, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prions replicate via the autocatalytic conversion of cellular prion protein (PrP C ) into fibrillar assemblies of misfolded PrP. While this process has been extensively studied in vivo and in vitro, non-physiological reaction conditions of fibril formation in vitro have precluded the identification and mechanistic analysis of cellular proteins, which may alter PrP self-assembly and prion replication. Here, we have developed a fibril formation assay for recombinant murine and human PrP (23-231) under near-native conditions (NAA) to study the effect of cellular proteins, which may be risk factors or potential therapeutic targets in prion disease. Genetic screening suggests that variants that increase syntaxin-6 expression in the brain (gene: STX6) are risk factors for sporadic Creutzfeldt–Jakob disease. Analysis of the protein in NAA revealed, counterintuitively, that syntaxin-6 is a potent inhibitor of PrP fibril formation. It significantly delayed the lag phase of fibril formation at highly sub-stoichiometric molar ratios. However, when assessing toxicity of different aggregation time points to primary neurons, syntaxin-6 prolonged the presence of neurotoxic PrP species. Electron microscopy and super-resolution fluorescence microscopy revealed that, instead of highly ordered fibrils, in the presence of syntaxin-6 PrP formed less-ordered aggregates containing syntaxin-6. These data strongly suggest that the protein can directly alter the initial phase of PrP self-assembly and, uniquely, can act as an ‘anti-chaperone’, which promotes toxic aggregation intermediates by inhibiting fibril formation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Qa-SNARE ProteinsAnimalsMiceHumansPrion ProteinsNeuronsProtein AggregatesCreutzfeldt-Jakob Syndrome

Stichwörter der Autor:innen

E. coliaggregationamyloidbiochemistrychaperonechemical biologymouseprionsyntaxintoxicity

Substanzen

Qa-SNARE ProteinsPrion ProteinsProtein Aggregates

Autor:innen und Institutionen

  • MRC Prion Unit at UCL, Institute of Prion Diseases, London, United Kingdom.

ORCID-Profile: Mark Batchelor, Jan Bieschke

Förderung

  • NINDS NIH HHS
  • Medical Research Council
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Sangar, D., Hill, E., Jack, K., Batchelor, M., Mistry, B., Ribes, J. M., Jackson, G. S., Mead, S., & Bieschke, J. (2024). Syntaxin-6 delays prion protein fibril formation and prolongs the presence of toxic aggregation intermediates. eLife. https://doi.org/10.7554/elife.83320

Vancouver

Sangar D, Hill E, Jack K, Batchelor M, Mistry B, Ribes JM, et al. Syntaxin-6 delays prion protein fibril formation and prolongs the presence of toxic aggregation intermediates. eLife. 2024. doi:10.7554/elife.83320

BibTeX
@article{Sangar2024,
  author = {Sangar, Daljit and Hill, Elizabeth and Jack, Kezia and Batchelor, Mark and Mistry, Beenaben and Ribes, Juan M and Jackson, Graham S and Mead, Simon and Bieschke, Jan},
  title = {Syntaxin-6 delays prion protein fibril formation and prolongs the presence of toxic aggregation intermediates},
  journal = {eLife},
  year = {2024},
  doi = {10.7554/elife.83320}
}
Kostenlos starten →